• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Medtech stories we missed this week: July 13, 2018

July 13, 2018 By Danielle Kirsh

missed-medtech-0713
[Image from unsplash.com]
From Angiodroid receiving CE Mark approval to Masimo launching its vital signs app, here are seven medtech stories we missed this week but thought were still worth mentioning.

1. Angiodroid wins CE Mark for Angiopulse IABP

Angiodroid announced in a July 11 press releasethat it has received CE Mark approval for its AngioPulse intra-aortic balloon pump device. The AngioPulse uses a new system for intra-aortic balloon pumps based on pressure regulation. It is designed for weaning solutions and is suitable for all types of patients needing intra-aortic balloon pump therapy.

2. Visura Technologies wins FDA nod for disposable TEE camera

Visura Technologies has received FDA 510(k) clearance for its TEE Camera Assist Device (TEECAD), according to a July 10 press release. The TEECAD has a single-use disposable camera that can be easily attached to a transesophageal echocardiogram (TEE) ultrasound probe to give physicians a view of the upper airway and esophagus during probe placement for a safe intubation process. The camera view can be viewed from a separate viewing system display to see real-time images from the camera.

3. FDA clears Oculocare’s Alleye wet AMD monitor

Oculocare announced in a July 9 press releasethat it has received FDA 510(k) clearance for its Alleye mobile medical software application. Alleye is designed to be used for detecting and monitoring age-related macular degeneration. It detects and characterizes central and paracentral metamorphopsia in patients who have macular conditions like AMD and diabetic retinopathy. Alleye gives patients the chance to regularly perform simple self-tests at home to help monitor eyesight or assess disease progression.

Get the full story on our sister site, MassDevice.

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Hospital Care, Imaging, Optical/Ophthalmic, Orthopedics, Patient Monitoring, Regulatory/Compliance, Surgical

IN CASE YOU MISSED IT

  • Lilly to submit once-weekly insulin for regulatory review this year following strong clinical results
  • Study finds MannKind inhaled insulin safe, effective for children
  • A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology
  • Dexcom continues advances in AI for CGM, type 2 diabetes awareness
  • Tandem continues to deliver more options, benefits for those with diabetes

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS